Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INSP Inspire Medical Systems Inc
- Stocks
- Healthcare
- NYSE: INSP
Price (delayed)
$152.79
Market cap
$4.51B
P/E Ratio
68.21
Dividend/share
N/A
EPS
$2.24
Enterprise value
$4.48B
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the
Highlights
The P/E is 73% below the last 4 quarters average of 250.0
The gross profit has grown by 27% YoY and by 4.6% from the previous quarter
The company's equity rose by 8% YoY but it fell by 8% QoQ
INSP's debt is up by 29% YoY and by 4.8% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inspiremedicalsystems.com
Peers:
OFIX
Key stats
What are the main financial stats of INSP
Market
Valuations
Earnings
Shares outstanding
29.49M
Market cap
$4.51B
Enterprise value
$4.48B
Price to earnings (P/E)
68.21
Price to book (P/B)
7.13
Price to sales (P/S)
5.4
EV/EBIT
62.29
EV/EBITDA
55.82
EV/Sales
5.34
Revenue
$840.11M
Gross profit
$711.17M
Operating income
$49.82M
Net income
$66.51M
EBIT
$71.99M
EBITDA
$80.33M
Free cash flow
$78.85M
Per share
Balance sheet
Liquidity
EPS
$2.24
EPS diluted
$2.17
Free cash flow per share
$2.65
Book value per share
$21.43
Revenue per share
$28.28
TBVPS
$24.6
Total assets
$730.81M
Total liabilities
$95.07M
Debt
$31.49M
Equity
$635.74M
Working capital
$508.21M
Debt to equity
0.05
Current ratio
9.01
Quick ratio
7.28
Net debt/EBITDA
-0.28
Margins
Efficiency
Dividend
EBITDA margin
9.6%
Gross margin
84.7%
Net margin
7.9%
Operating margin
5.9%
Return on assets
8.7%
Return on equity
10%
Return on invested capital
12.3%
Return on capital employed
10.8%
Return on sales
8.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INSP stock price
How has the Inspire Medical Systems stock price performed over time
Intraday
-2.37%
1 week
-3.24%
1 month
8.05%
1 year
-6.5%
YTD
-17.58%
QTD
-4.07%
Financial performance
How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$840.11M
Gross profit
$711.17M
Operating income
$49.82M
Net income
$66.51M
Gross margin
84.7%
Net margin
7.9%
The operating income has grown by 38% since the previous quarter
The operating margin is up by 31% from the previous quarter
The gross profit has grown by 27% YoY and by 4.6% from the previous quarter
Inspire Medical Systems's revenue has increased by 27% YoY and by 4.6% from the previous quarter
Price vs fundamentals
How does INSP's price correlate with its fundamentals
Growth
What is Inspire Medical Systems's growth rate over time
Valuation
What is Inspire Medical Systems stock price valuation
P/E
68.21
P/B
7.13
P/S
5.4
EV/EBIT
62.29
EV/EBITDA
55.82
EV/Sales
5.34
The P/E is 73% below the last 4 quarters average of 250.0
INSP's EPS is up by 24% since the previous quarter
The P/B is 56% below the 5-year quarterly average of 16.3 and 7% below the last 4 quarters average of 7.7
The company's equity rose by 8% YoY but it fell by 8% QoQ
The stock's P/S is 73% less than its 5-year quarterly average of 20.0 and 18% less than its last 4 quarters average of 6.6
Inspire Medical Systems's revenue has increased by 27% YoY and by 4.6% from the previous quarter
Efficiency
How efficient is Inspire Medical Systems business performance
INSP's ROA is up by 23% from the previous quarter
INSP's ROE is up by 22% since the previous quarter
INSP's return on sales is up by 18% since the previous quarter
INSP's ROIC is up by 14% from the previous quarter
Dividends
What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INSP.
Financial health
How did Inspire Medical Systems financials performed over time
The current ratio rose by 26% since the previous quarter and by 14% year-on-year
The company's quick ratio rose by 20% QoQ and by 2.2% YoY
INSP's debt is 95% lower than its equity
INSP's debt is up by 29% YoY and by 4.8% QoQ
INSP's debt to equity is up by 25% since the previous quarter and by 25% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.